OBLITERATE

Manufacturer
mybody
Effective date
2012-05-02
Label type
HUMAN OTC DRUG LABEL
Version
7
Source
full-release
Hydrated at
2026-05-31 22:31:35

Label at a glance#

ProductOBLITERATE
Active ingredientBENZOYL PEROXIDE
Label structure13 sections

Label contents#

Full prescribing information#

OTC - ACTIVE INGREDIENT SECTION

ACTIVE INGREDIENT         BENZOYL PEROXIDE 5%

OTC - PURPOSE SECTION

PURPOSE         ACNE TREATMENT

INDICATIONS & USAGE SECTION

USE FOR TREATMENT OF ACNE

WARNINGS SECTION

WARNINGS

FOR EXTERNAL USE ONLY

OTC - DO NOT USE SECTION

DO NOT USE * IF YOU HAVE VERY SENSITIVE SKIN OR ARE SENSITIVE TO BENZOYL PEROXIDE.

OTC - ASK DOCTOR/PHARMACIST SECTION

ASK A DOCTOR OR PHARMACIST BEFORE USE IF * PREGNANT OR LACTATING. YOU ARE USING OTHER TOPICAL ACNE MEDICATIONS AT THE SAME TIME OR IMMEDIATELY FOLLOWING USE OF THIS PRODUCT. THIS MAY INCREASE DRYNESS OR IRRITATION OF THE SKIN. IF THIS OCCURS, ONLY ONE MEDICATION SHOULD BE USED UNLESS DIRECTED BY A DOCTOR.

OTC - WHEN USING SECTION

WHEN USING THIS PRODUCT * AVOID CONTACT WITH EYES. IF CONTACT OCCURS, FLUSH THOROUGHLY WITH WATER. * KEEP AWAY FROM LIPS AND MOUTH.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

KEEP OUT OF REACH OF CHILDREN * IF SWALLOWED, GET MEDICAL HELP OR CONTACT A POISON CONTROL CENTER RIGHT AWAY.

DOSAGE & ADMINISTRATION SECTION

DIRECTIONS

* AM: APPLY SIDE 1 BENZOYL PEROXIDE TO CLEAN SKIN.

PM: APPLY SIDE 1 BENZOYL PEROXIDE TO CLEAN SKIN. ALLOW TO DRY. NEXT APPLY SIDE 2 WITH RETINOL. ALLOW TO DRY. DAILY USE OF SUNSCREEN IS RECOMMENDED. * IF BOTHERSOME DRYNESS OR PEELING OCCURS, REDUCE APPLICATION TO ONCE EVERY OTHER DAY.

OTHER SAFETY INFORMATION

OTHER INFORMATION

* AVOID STORAGE AT EXTREME TEMPERATURES (BELOW 40°F AND ABOVE 100°F).

INACTIVE INGREDIENT SECTION

INACTIVE INGREDIENTS CHAMBER A: WATER,  POLYACRYLAMIDE, C13-14 ISOPARAFFIN, LAURETH-7, ACETYL CARBOXYMETHYL COCOYL GLYCINE, PHENOXYETHANOL, CAPRYLYL GLYCOL, DECYLENE GLYCOL, CARBOMER.

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

MYBODY

OBLITERATE

BOOSTER PACK: ACTIVE ACNE

MYBOOSTER * STEP 2


obliterate_INNER LBLobliterate_INNER LBL


OBLITERATE_OUTER_BOX_Drug Facts PanelOBLITERATE_OUTER_BOX_Drug Facts Panel

OBLITERATE_OUTER_BOX_FrontOBLITERATE_OUTER_BOX_Front

DailyMed Pharmacologic Classes#

Class, Version, Type table
ClassVersionTypeEffective
BENZOIC ACID Pharmacologic Class Indexing2Indexing - Pharmacologic Class20180813

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
a46239a7-5963-4008-8cbb-6b9000f497ebProduct name120250721
b382b4e1-6b48-45f6-bffc-e61b00b0ce19Product name320250317
d9d61457-6a5a-41fc-b418-e5479a2904b7Product name220230303
32012d5c-25ac-49c7-9d4c-1313177fff7cProduct name120230112
13e7e7e3-e885-4c79-af6d-dad1aedbb06eProduct name120220128
c6f86816-7da6-43ea-8c25-ac9758311cc5Product name120220118
4a7d44fe-774d-404b-aad0-8a90fe78375aProduct name420211025
3f45980c-c196-47e5-0e5e-48b7c57327c5Product name520200428
d12e2d7c-bd6b-45d4-94f9-6df8e1b8b27bProduct name320200203
ee5c6de5-d9cd-454f-b250-7b19e5cf2992Product name420190619
ad75fcfd-a339-42a1-9c60-43ba2c654cfaProduct name120170810
252e11b6-1a9a-4283-a242-df2c129c496dProduct name320170717

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
49520-101-512019-11-13C16284748780-197449f38-d1b4-f6ea-e053-dbdaa90aa703OBLITERATE

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
49520-101-11OBLITERATE15 mL in 1 BOTTLELOTION157
49520-101-51OBLITERATE1 in 1 BOXLOTION17

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
49520-101OBLITERATE (BENZOYL PEROXIDE) LOTION [MYBODY]7Legacy NDC, 2 package rows20120502_1236c740-8d51-47ac-b305-1d959cae6c53.zip

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIISPL versionUploaded
BENZOYL PEROXIDEACTIVE INGREDIENTW9WZN9A0GM7
BENZOIC ACIDACTIVE MOIETY8SKN0B0MIM7
ACETYL CARBOXYMETHYL COCOYL GLYCINEINACTIVE INGREDIENT3TNX4P92J37
C13-14 ISOPARAFFININACTIVE INGREDIENTE4F12ROE707
CAPRYLYL GLYCOLINACTIVE INGREDIENT00YIU5438U7
CARBOMER HOMOPOLYMER (ALLYL SUCROSE CROSSLINKED)INACTIVE INGREDIENTZ135WT92087
DECYLENE GLYCOLINACTIVE INGREDIENTS57M60MI887
LAURETH-7INACTIVE INGREDIENTZ95S6G82017
PHENOXYETHANOLINACTIVE INGREDIENTHIE492ZZ3T7
POLYACRYLAMIDE (1500 MW)INACTIVE INGREDIENT5D6TC4BRWV7
WATERINACTIVE INGREDIENT059QF0KO0R7

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 12 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
49520-10149520-101-11, 49520-101-51

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 10 matching rows.

Source Document#

Source XML

Inactive ingredient matches#

Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.

Inactive ingredient links page 1 of 1 · 20 matching rows.

DailyMed ingredient, IID ingredient, UNII table
DailyMed ingredientIID ingredientUNIIDosage form / routePotencyMaximum daily exposureMatch
PHENOXYETHANOLPHENOXYETHANOLHIE492ZZ3TGEL / TOPICAL14 mgExact identifier — unii candidate
6 equally ranked IID candidates
CARBOMER HOMOPOLYMER (ALLYL SUCROSE CROSSLINKED)CARBOMER HOMOPOLYMER TYPE B (ALLYL SUCROSE CROSSLINKED)Z135WT9208SUSPENSION / OPHTHALMIC0.45 %w/wExact identifier — unii candidate
14 equally ranked IID candidates
CARBOMER HOMOPOLYMER (ALLYL SUCROSE CROSSLINKED)CARBOMER HOMOPOLYMER TYPE B (ALLYL SUCROSE CROSSLINKED)Z135WT9208SUSPENSION / ORAL288 mgExact identifier — unii candidate
14 equally ranked IID candidates
PHENOXYETHANOLPHENOXYETHANOLHIE492ZZ3TAEROSOL / TOPICAL1.05 %w/wExact identifier — unii candidate
6 equally ranked IID candidates
CARBOMER HOMOPOLYMER (ALLYL SUCROSE CROSSLINKED)CARBOMER HOMOPOLYMER TYPE B (ALLYL SUCROSE CROSSLINKED)Z135WT9208OINTMENT / TOPICAL0.5 %w/wExact identifier — unii candidate
14 equally ranked IID candidates
CARBOMER HOMOPOLYMER (ALLYL SUCROSE CROSSLINKED)CARBOMER HOMOPOLYMER TYPE B (ALLYL SUCROSE CROSSLINKED)Z135WT9208SOLUTION / TOPICAL10 mgExact identifier — unii candidate
14 equally ranked IID candidates
PHENOXYETHANOLPHENOXYETHANOLHIE492ZZ3TCREAM, AUGMENTED / TOPICAL10 mgExact identifier — unii candidate
6 equally ranked IID candidates
PHENOXYETHANOLPHENOXYETHANOLHIE492ZZ3TCREAM / TOPICAL57 mgExact identifier — unii candidate
6 equally ranked IID candidates
CARBOMER HOMOPOLYMER (ALLYL SUCROSE CROSSLINKED)CARBOMER HOMOPOLYMER TYPE B (ALLYL SUCROSE CROSSLINKED)Z135WT9208CREAM / TOPICAL600 mgExact identifier — unii candidate
14 equally ranked IID candidates
CARBOMER HOMOPOLYMER (ALLYL SUCROSE CROSSLINKED)CARBOMER HOMOPOLYMER TYPE B (ALLYL SUCROSE CROSSLINKED)Z135WT9208TABLET, EXTENDED RELEASE / ORAL90 mgExact identifier — unii candidate
14 equally ranked IID candidates
CARBOMER HOMOPOLYMER (ALLYL SUCROSE CROSSLINKED)CARBOMER HOMOPOLYMER TYPE B (ALLYL SUCROSE CROSSLINKED)Z135WT9208GEL, METERED / TRANSDERMAL1 %w/wExact identifier — unii candidate
14 equally ranked IID candidates
CARBOMER HOMOPOLYMER (ALLYL SUCROSE CROSSLINKED)CARBOMER HOMOPOLYMER TYPE B (ALLYL SUCROSE CROSSLINKED)Z135WT9208SUSPENSION/ DROPS / OPHTHALMIC0.4 %w/vExact identifier — unii candidate
14 equally ranked IID candidates
CARBOMER HOMOPOLYMER (ALLYL SUCROSE CROSSLINKED)CARBOMER HOMOPOLYMER TYPE B (ALLYL SUCROSE CROSSLINKED)Z135WT9208TABLET, ORALLY DISINTEGRATING / ORAL1 mgExact identifier — unii candidate
14 equally ranked IID candidates
CARBOMER HOMOPOLYMER (ALLYL SUCROSE CROSSLINKED)CARBOMER HOMOPOLYMER TYPE B (ALLYL SUCROSE CROSSLINKED)Z135WT9208ENEMA / RECTAL0.24 %w/vExact identifier — unii candidate
14 equally ranked IID candidates
CARBOMER HOMOPOLYMER (ALLYL SUCROSE CROSSLINKED)CARBOMER HOMOPOLYMER TYPE B (ALLYL SUCROSE CROSSLINKED)Z135WT9208LOTION / TOPICAL21 mgExact identifier — unii candidate
14 equally ranked IID candidates
CARBOMER HOMOPOLYMER (ALLYL SUCROSE CROSSLINKED)CARBOMER HOMOPOLYMER TYPE B (ALLYL SUCROSE CROSSLINKED)Z135WT9208EMULSION / TOPICAL3405 mgExact identifier — unii candidate
14 equally ranked IID candidates
PHENOXYETHANOLPHENOXYETHANOLHIE492ZZ3TLOTION / TOPICAL1 %w/wExact identifier — unii candidate
6 equally ranked IID candidates
PHENOXYETHANOLPHENOXYETHANOLHIE492ZZ3TAEROSOL, FOAM / TOPICAL75 mgExact identifier — unii candidate
6 equally ranked IID candidates
CARBOMER HOMOPOLYMER (ALLYL SUCROSE CROSSLINKED)CARBOMER HOMOPOLYMER TYPE B (ALLYL SUCROSE CROSSLINKED)Z135WT9208CAPSULE / ORAL32 mgExact identifier — unii candidate
14 equally ranked IID candidates
CARBOMER HOMOPOLYMER (ALLYL SUCROSE CROSSLINKED)CARBOMER HOMOPOLYMER TYPE B (ALLYL SUCROSE CROSSLINKED)Z135WT9208GEL / TOPICAL30 mgExact identifier — unii candidate
14 equally ranked IID candidates

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
3985a28f-9688-405e-ac32-602c06f45d9c1236c740-8d51-47ac-b305-1d959cae6c532012-05-02WarningsExact identifier
spl id: 3985a28f-9688-405e-ac32-602c06f45d9c
spl set id: 1236c740-8d51-47ac-b305-1d959cae6c53

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.